Multicenter phase I/II trial of topotecan (T) and ifosfamide (I) combination as second-line therapy for pediatric solid cancer: Phase II results. This is an ASCO Meeting Abstract from the 2013 ASCO ...
Metabolic profiles as predictive biomarkers of erlotinib-induced adverse effects in patients with non-small cell lung cancer. Combination of the immunocytokine F16-IL2 with doxorubicin or paclitaxel ...
Folate deficiency anemia occurs when a person has a low level of folate, or vitamin B-9, in their body. Folate plays a vital role in many bodily processes, such as creating red blood cells and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results